Bayer sets new targets goal amid US weedkiller lawsuits

Bayer said it was targeting growth in adjusted core profit of 7% to 9.6% this year, driven by sales of agriculture products and pharmaceuticals, despite facing multiple legal cases in the US over cancer claims.

Bayer, which is fighting costly lawsuits over claims its glyphosate-based weedkillers cause cancer, laid out a goal for earnings for special items and currency swings to reach up to €12.6bn in 2019.